A detailed history of Raymond James & Associates transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Raymond James & Associates holds 6,120 shares of PPH stock, worth $559,857. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,120
Previous 4,965 23.26%
Holding current value
$559,857
Previous $404,000 37.38%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$82.63 - $90.89 $95,437 - $104,977
1,155 Added 23.26%
6,120 $555,000
Q4 2023

Jan 16, 2024

BUY
$74.32 - $81.37 $5,796 - $6,346
78 Added 1.6%
4,965 $404,000
Q3 2023

Oct 24, 2023

BUY
$76.26 - $83.18 $61,008 - $66,544
800 Added 19.57%
4,887 $390,000
Q2 2023

Jul 25, 2023

SELL
$75.02 - $80.55 $196,477 - $210,960
-2,619 Reduced 39.05%
4,087 $321,000
Q1 2023

Apr 14, 2023

SELL
$73.68 - $79.63 $1.72 Million - $1.86 Million
-23,307 Reduced 77.66%
6,706 $520,000
Q4 2022

Feb 08, 2023

BUY
$71.66 - $79.26 $1.19 Million - $1.32 Million
16,613 Added 123.98%
30,013 $2.33 Million
Q3 2022

Oct 25, 2022

BUY
N/A
40 Added 0.3%
13,400 $901,000
Q2 2022

Aug 12, 2022

BUY
N/A
1,929 Added 16.88%
13,360 $1.03 Million
Q1 2022

May 11, 2022

BUY
N/A
1,144 Added 11.12%
11,431 $912,000
Q4 2021

Feb 08, 2022

BUY
N/A
10,287 New
10,287 $792,000
Q3 2021

Nov 02, 2021

SELL
N/A
-3,609 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
N/A
-12 Reduced 0.33%
3,609 $264,000
Q1 2021

May 14, 2021

SELL
N/A
-66 Reduced 1.79%
3,621 $250,000
Q4 2020

Feb 12, 2021

SELL
N/A
-600 Reduced 14.0%
3,687 $245,000
Q2 2020

Jul 28, 2020

BUY
N/A
78 Added 1.85%
4,287 $267,000
Q1 2020

Apr 21, 2020

BUY
N/A
600 Added 16.63%
4,209 $229,000
Q4 2019

Feb 12, 2020

BUY
N/A
3,609 New
3,609 $232,000
Q2 2019

Aug 06, 2019

SELL
N/A
-5,100 Closed
0 $0
Q4 2018

Feb 11, 2019

SELL
N/A
-84,114 Reduced 94.28%
5,100 $279,000
Q3 2018

Nov 14, 2018

SELL
N/A
-2,292 Reduced 2.5%
89,214 $5.74 Million
Q2 2018

Aug 14, 2018

SELL
N/A
-769 Reduced 0.83%
91,506 $5.4 Million
Q1 2018

May 14, 2018

BUY
N/A
673 Added 0.73%
92,275 $5.24 Million
Q4 2017

Feb 14, 2018

BUY
N/A
3,087 Added 3.49%
91,602 $5.43 Million
Q3 2017

Nov 13, 2017

SELL
N/A
-9,011 Reduced 9.24%
88,515 $5.11 Million
Q2 2017

Aug 14, 2017

BUY
N/A
97,526
97,526 $5.76 Million

Others Institutions Holding PPH

About VANECK ETF TR VANECK PHARMACEU


  • Ticker PPH
  • Sector ETFs
  • Industry ETFs
More about PPH
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.